Research Article

Seroprevalence of Measles Specific IgG Antibody among Children in Adamawa State Nigeria

Isa, H.1*, Ja’afaru, M. I.1, Bashir, M2, Suleiman, Y. A.3
1 Department of Microbiology, school of life sciences, Modibbo Adama University of Technology, Yola.
2 Centre for Dryland Agriculture, Bayero University, Kano-Nigeria.
3 Department of Medical Laboratory Science, College of Health Technology, Mubi.
* Corresponding author: isah@nsmjournal.org.ng
Published: Jun, 2019
DOI: 10.67614/njm.2019.0k8akuuy
Pages: 4450-4454

Abstract

Measles account for nearly half of the 1.7 million annual deaths due to childhood vaccine-preventable diseases. Presence of measles specific IgG antibodies has been proven to correlate with protection (immunity) to natural measles infection. This study was therefore designed to determine the seroprevalence of measles specific IgG in relation to vaccination status, types of settlement and parents’ occupation among children aged 0-14 years in Adamawa State. The research was carried out within the three senatorial districts of the State. Three hundred and sixty eight (368) serum samples collected from children were used to determine the prevalence using ELISA technique. Questionnaire was used to obtain demographic data of the children. The study revealed that 227 (61.6%) of the children had protective measles IgG antibody, while 141 (38.4%) had unprotective or no measles IgG antibody. Statistical analysis revealed that there was significant association between prevalence of measles specific IgG antibody and vaccination status against measles, types of settlement and parents’ occupation (p-value < 0.05).

Keywords

Demographic data ELISA IgG Antibody Measles virus Prevalence Vaccination

References

  1. Aaby, P., Bukh, J., Leerhoy, J. (1986) Vaccinated children get milder measles infection, a community study from Guinea-Bissau. Journal of Infectious Diseases;154:858-63.
  2. Baba M. M., Omede, Charity, S., Omotara, B. A. Ambe, J. P. (2007). Evaluation of Measles Vaccines in Northeastern Nigeria. Nature and Science, 5(3).
  3. Bartoloni, P., Cutts, F.T., Guglielmetti, F.G., Brown, M.L. and Roselli, M. (2004). Prevalence of measles antibody among children under 15 years of age in santa cruz, Bolivia; implications for vaccination strategies. January-February 1995, pp 119-122.
  4. Black, F.L. and Yannet, H. (1960) Inapparent Measles after gammoglobulin administration. Journal of the American Medical Association 73:1183-1188.
  5. Centre for Disease Control and Prevention (2015): Measles: Questions and Answers. Information about the disease and vaccine. Retrieved [online] from www.vaccineinformation.org/catg.d/pd92.pdf on 10th March, 2015.
  6. Damien, B., Huiss, S., Schneider, F., Muller, C. P. (1998). Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. J Med Virol. 56(1):85–90.
  7. Demedictect Diagnostics (2018). Measles IgG ELISA (DEMSA01) for the detection and quantitative determination of human IgG antibodies against measles virus in serum and plasma. Product information/ user manual.
  8. Edmonson, M. B., Addiss, D. G., McPherson, J.T. (1990). Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2466-7.
  9. Janal, M.K., Paul, G.Q. and Henry, H.B. (2011). Measles susceptibility among elementary school children. American Journal Epidemiology 173:2
  10. Markowitz, L.E., Preblid, S.R., Fine, P.E.M., Orenstein, W.A. (1990). Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 9:101-10.
  11. Mossong, J., Muller, C. P (2000) Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol Infect;124:273-8.
  12. Mossong, J, Nokes, D. J, Edmunds, W. J, Cox, M. J., Ratnam, S., Muller, C. P.(1999). Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol. 150(11):1238-49.
  13. Mossong, J. and Muller, C.P. (2003). Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine 21:4597-4603.
  14. Naing, L., Winn, T. and Rusli, B. N. (2006). Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences 1:9-14.
  15. Van den Hof, S., Berbers, G.A., de Melker, H.E., Conyn-van Spaendonck, M. A. (1999) Sero-epidemiology of measles antibodies in the Netherlands, a national sample and in communities with low vaccine coverage. Vaccine. 18(9–10):931–40.
  16. World Health Organization (2001). Global Measles Mortality Reduction and Regional Elimination Strategic Plan 2001-2005. World Health Organization, Geneva, Switzerland.
  17. World Health Organization (2008). Immunological Basis for Immunization Series Module xx: Measles. Geneva, Switzerland
  18. World Health Organization (2018). Manual for the laboratory diagnosis of measles virus infection. WHOV.eB/00.16.
How to Cite

H., I., I., J. M., M, B., & A., S. Y. (2019). Seroprevalence of Measles Specific IgG Antibody among Children in Adamawa State Nigeria. Nigerian Journal of Microbiology, 33(1), 4450-4454. https://doi.org/10.67614/njm.2019.0k8akuuy

I. H., J. M. I., B. M, and S. Y. A., "Seroprevalence of Measles Specific IgG Antibody among Children in Adamawa State Nigeria," Nigerian Journal of Microbiology, vol. 33, no. 1, pp. 4450-4454, June 2019. doi: 10.67614/njm.2019.0k8akuuy

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles